WHX Dubai 2027
Meet SEBERS Medical at WHX Dubai 2027
Join SEBERS Medical at World Health Expo (WHX) Dubai 2027, one of the world’s largest healthcare and medical technology exhibitions, where healthcare professionals, hospitals, distributors, researchers, and industry leaders come together to discover the latest innovations shaping the future of medicine. As the global meeting point for healthcare technology, WHX provides the ideal platform to explore the next generation of Transcranial Magnetic Stimulation (TMS) for both clinical practice and neuroscience research.
Blossom TMS™ – Designed for Everyday Clinical Excellence
Discover the Blossom TMS™ Therapy System, our FDA-cleared and CE-marked TMS solution developed to simplify clinical workflows while delivering reliable and reproducible treatment for Major Depressive Disorder (MDD).
Designed around the needs of modern TMS clinics, Blossom TMS combines powerful technology with exceptional ease of use. The system features high-performance liquid coil cooling for continuous operation, integrated motor threshold determination, intuitive touchscreen software, pre-installed treatment protocols, and the patented HeadNest™ positioning system for fast, comfortable, and reproducible patient setup.
Unlike many conventional TMS systems, Blossom TMS is built for long-term ownership with no pay-per-use fees, no artificially limited lifetime, and no costly disposable components. Whether you are opening your first TMS clinic or expanding an established neuromodulation center, Blossom TMS delivers efficiency, reliability, and an outstanding user experience.
Blossom² – Exploring the Future of Neuroplasticity
WHX Dubai visitors will also have the opportunity to experience Blossom², our next-generation research TMS platform engineered to advance the understanding of neuroplasticity, brain connectivity, and adaptive neuromodulation.
Blossom² has been designed to provide researchers with unprecedented flexibility for developing and reproducing sophisticated stimulation paradigms. The platform combines:
- Fingerprint TMS™ with individualized stimulation timing
- Fully programmable stimulation protocols
- Single-pulse, paired-pulse, rTMS, TBS, QPS, iQPS and custom pulse sequences
- Ultra-fine 100 µs timing resolution
- Programmable burst architectures
- Stimulation frequencies of up to 1,000 Hz within burst sequences
- AI-ready system architecture
- Open interfaces for EEG, EMG, neuronavigation, and external research devices
- Advanced trigger input and output capabilities for synchronized experiments
- Flexible software architecture supporting future research applications
These capabilities enable researchers to investigate cortical excitability, I-wave-dependent stimulation, plasticity mechanisms, brain network dynamics, and personalized neuromodulation strategies with a level of precision that has previously required multiple independent research systems.
Blossom² has also been developed with the future of closed-loop TMS in mind. Its open communication architecture provides the technological foundation for future AI-assisted protocol optimization, biomarker-guided stimulation, EEG-triggered neuromodulation, and intelligent adaptive brain stimulation strategies.
TMS Pilot™ – Precision Made Simple
Experience the TMS Pilot™, our innovative coil-mounted positioning system that introduces a new level of precision and workflow efficiency to TMS.
Unlike conventional positioning methods, the TMS Pilot allows clinicians and researchers to visualize the stimulation target directly beneath the coil. Real-time visual guidance supports accurate coil placement, simplifies repositioning between treatment sessions, and improves reproducibility throughout longitudinal clinical studies and therapeutic treatment courses.
Whether used in daily psychiatric practice or advanced neuroscience research, the TMS Pilot helps standardize stimulation procedures while reducing setup time and increasing operator confidence.
From Clinical Excellence to the Future of Neuroplasticity
Whether you are a psychiatrist, neurologist, neuroscientist, hospital administrator, distributor, or research institution, we invite you to visit SEBERS Medical at WHX Dubai 2027 and discover our complete portfolio of next-generation TMS technologies.
From the clinically proven Blossom TMS™ Therapy System, to the innovative TMS Pilot™, and the groundbreaking Blossom² research platform for neuroplasticity and future closed-loop neuromodulation, we are committed to shaping the next generation of brain stimulation technology.
SEBERS Medical – From Clinical Excellence to the Future of Neuroplasticity.